Reddit Inc vs Viatris Inc — how do they compare? Reddit Inc trades at $159.84 (market cap $30.10B), while Viatris Inc trades at $17.64 (market cap $20.03B). The key difference: Reddit Inc is the larger of the two by market cap, and Viatris Inc pays a 2.75% dividend while Reddit Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Reddit Inc for 26 Days and Viatris Inc for 57 Days on average.
| RDDT | VTRS | |
|---|---|---|
Market Cap | $30.10B | $20.03B |
Volume | 4,560,440 | 14,109,977 |
Sector | Media | Health |
52-Week High | $258.93 | $18.27 |
52-Week Low | $121.84 | $9.74 |
Typical Hold Time | 26 Days | 57 Days |
Enterprise Value | $27.34B | $32.15B |
Dividend Yield | — | 2.75% |
Signals from Pluang's Aura AI — not financial advice
Reddit (RDDT) trades at $159.84, up 4.63% today, showing strong momentum after three consecutive quarterly earnings beats. The stock maintains a bullish technical outlook with support at $154 and resistance at $160. Fundamentally, the company demonstrates exceptional profitability with 91.44% gross margins and 31.35% net income margins, while revenue growth accelerated to $2.8 billion in 2026. Recent developments include a strategic partnership with Zefr for AI-powered advertising solutions and expanding international revenues by 84%.
The investment outlook remains positive with 65.5% analyst buy ratings and a $202.52 consensus price target representing 27% upside potential. Key opportunities include continued AI data licensing growth and international expansion, while risks involve competitive pressure from Meta and regulatory concerns. The stock's premium valuation at 36.4x P/E requires sustained execution to justify current levels.
Viatris (VTRS) trades at $17.44, down 0.29% on the day, with a bullish technical signal from moving averages and oversold short-term RSI. The company reported three consecutive quarterly earnings beats in 2026, with Q2 EPS of $0.69 beating estimates by 14.8%. Revenue for 2025 was $14.3B, though net income was negative $3.51B, reflecting margin pressure. Positive news includes a new drug approval in Japan and recognition as a top employer.
The outlook is mixed: strong cash flow generation and deleveraging support shareholder returns via dividends and buybacks, but profitability challenges and high debt levels pose risks. Analyst consensus is a 'Buy' with a $22.17 price target, implying 27% upside. Investment appeal hinges on execution of pipeline growth and margin improvement amid competitive and pricing pressures in the generics market.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Reddit Inc. operates a vast network of online communities organized around various interests, known as 'subreddits'. Functioning as a hybrid of a social media platform and a discussion forum, the company generates revenue primarily through advertising and premium subscriptions. Reddit is a major hub for user-generated content, trending news, and viral discussions, and it is a key player in the digital advertising and social media landscape.
Read more on RDDT →Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).
Read more on VTRS →